Search

everythinglearnresearchcommunity

for

Search:↓

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Valproate is a mood stabilizer for bipolar disorder but has side effects and risks, especially during pregnancy.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Type 2 diabetes does not change how metformin works in obese pregnant women, so dosage adjustments are not needed.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

The critique suggests that Wilton's work unintentionally supports the very stereotypes it aims to question and calls for a broader, more inclusive approach to understanding gender.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Hirsutism causes significant psychological distress in women.